![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Levetiracetam, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-325 - Rev 00
This Chemical Type CEP, issued on February 20, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2535 associated with this CEP further emphasizes